Replies to post #69571 on Ocata Therapeutics Inc fka OCAT

[lasers]

$ACTC choosing the immune privileged eye site is a brilliant decision by Dr. Lanza as very little and mostly no anti-rejection chemical is needed for the hESC RPE DNA donor to be accepted by the host's DNA Bruch Membrane!